Neostigmine Methylsulfate Injection
Product Images NDC 71839-106

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 71839-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neo10mgcarton10

Packaging label for Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) by BE Pharmaceuticals Inc. The label indicates the product is for intravenous use, supplied in 10 x 10 mL multiple dose vials. The label includes storage instructions, active ingredient details, and manufacturer contact information, with Rx only designation.*

FDA Label Image

Neo10mgcartonlabel

Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) multiple dose vial label. The label includes NDC 71839-106-01 and directions for intravenous use. It states the product contains Neostigmine Methylsulfate 1 mg per mL with preservatives and instructions for storage at 20° to 25°C, protecting from light. Distributed by BE Pharmaceuticals Inc., Cary, NC, made in India.*

FDA Label Image

Neo10mgoutercartonlabel

Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) in multiple dose vials. The injection is for intravenous use and supplied in a carton containing 24 vials of 10 mL each. The label shows the product is distributed by BE Pharmaceuticals Inc., made in India, and includes storage instructions and preservatives information.*

FDA Label Image

Neo10mgviallabel

Label for Neostigmine Methylsulfate Injection USP, 10 mg/10 mL (1 mg/mL) for intravenous use. The label specifies a 10 mL multiple dose vial and mentions the contents including Neostigmine Methylsulfate Sulfate 1 mg, phenol as preservative, sodium acetate, and water for injection. Storage instructions and manufacturer details for BE Pharmaceuticals Inc., Cary, NC, are provided along with batch and expiration fields.*

FDA Label Image

Neo5mgcarton10

Packaging label for Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) for intravenous use. The label indicates a 10 x 10 mL multiple dose vial distributed by BE Pharmaceuticals Inc., Cary, NC. Storage instructions and ingredient details are included, with Rx only designation and barcode visible.*

FDA Label Image

Neo5mgcartonlabel

Label for Neostigmine Methylsulfate Injection, USP 0.5 mg/mL intravenous injection from BE Pharmaceuticals Inc. It is a 10 mL multiple dose vial containing 5 mg per 10 mL solution. The label includes storage instructions, ingredients, usage directions, and manufacturing details, with a predominantly white background and purple highlight for strength.*

FDA Label Image

Neo5mgoutercartonlabel

Packaging label for Neostigmine Methylsulfate Injection, USP, 5 mg/10 mL (0.5 mg/mL) for intravenous use. The label states 24 x 10 mL multiple dose vials. The labeler is BE Pharmaceuticals Inc., with distribution address in Cary, NC. Storage instructions and other product details are included in small print. The label features barcodes and NDC 71839-105-24.*

FDA Label Image

Neo5mgviallabel

Label for Neostigmine Methylsulfate Injection USP, 5 mg/10 mL (0.5 mg/mL) for intravenous use in a 10 mL multiple dose vial. Distributed by BE Pharmaceuticals Inc., Cary, NC, made in India. The label includes storage instructions, ingredients, and a barcode with lot and expiration date fields.*

FDA Label Image

Neologo (Neologo)

FDA Label Image

Neostr (Neostr)

Chemical structure of Neostigmine methylsulfate, showing the molecular arrangement including the aromatic ring, nitrogen atoms, and the methyl sulfate group (CH3SO4-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.